3021
Transcreener® GDP TR-FRET Assay
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
UNSPSC Code:
41122100
NACRES:
NA.84
Productos recomendados
shipped in
dry ice
storage temp.
−20°C
General description
The Transcreener® GDP TR-FRET Red Assay is a competitive immunoassay for GDP with a far-red, time-resolved Förster-resonance-energy-transfer (TR-FRET) readout. Because it is highly selective for GDP, the assay can be used with any enzyme that converts GTP to GDP, regardless of what other substrates are used. Examples of enzymes include GTPases and fucosyltransferases. The Transcreener® assay is designed specifically for high-throughput screening (HTS), with a single-addition, mix-and-read format. It offers reagent stability and compatibility with commonly used multimode plate readers. The generic nature of the Transcreener® HTS assay platform eliminates delays involved in assay development for new HTS targets and greatly simplifies compound and inhibitor profiling across multiple target families.
The Transcreener® GDP TR-FRET Red Assay provides the following benefits:
View full Transcreener® product list
The Transcreener® GDP TR-FRET Red Assay provides the following benefits:
- Accommodates GTP concentrations ranging from 0.1 μM to 1,000 μM.
- Excellent data quality (Z′ = 0.7) at low substrate conversion (typically 10–30%).
- Overcomes the need for time-consuming, one-off assay development for individual members within a group transfer enzyme family by using a single set of assay reagents that detect an invariant product.
- Time-gated detection method largely eliminates interference that can result from prompt fluorescence of test compounds.
- Far-red tracer further minimizes interference from fluorescent compounds and light scattering.
View full Transcreener® product list
Quantity
3021-1K = 1,000 assay, 384-well
3021-10K = 10,000 assay, 384-well
3021-10K = 10,000 assay, 384-well
Physical form
Kit with buffered aqueous solutions
Legal Information
Transcreener is a registered trademark of BellBrook Labs
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
N Levek-Motola et al.
Human reproduction (Oxford, England), 20(12), 3469-3475 (2005-08-27)
The pathway of spermatogenesis involves the conversion of diploid stem cells (spermatogonia) to tetraploid primary spermatocytes, followed by meiosis and two cell divisions, first forming diploid secondary spermatocytes and then haploid round spermatids. Differentiation of round spermatids results in spermatozoa
Cord blood in vitro expanded CD41 cells: identification of novel components of megakaryocytopoiesis.
A Balduini et al.
Journal of thrombosis and haemostasis : JTH, 4(4), 848-860 (2006-04-26)
Megakaryopoiesis represents a multi-step, often unclear, process leading to commitment, differentiation, and maturation of megakaryocytes (MKs) that release platelets. To identify the novel genes that might help to clarify the molecular mechanisms of megakaryocytopoiesis and be regarded as potential candidates
Lauriane Simon et al.
Nucleic acids research, 46(6), 3019-3033 (2018-03-09)
Organized in tandem repeat arrays in most eukaryotes and transcribed by RNA polymerase III, expression of 5S rRNA genes is under epigenetic control. To unveil mechanisms of transcriptional regulation, we obtained here in depth sequence information on 5S rRNA genes
Carolin Lepa et al.
Journal of the American Society of Nephrology : JASN, 32(2), 357-374 (2021-01-01)
Injury to kidney podocytes often results in chronic glomerular disease and consecutive nephron malfunction. For most glomerular diseases, targeted therapies are lacking. Thus, it is important to identify novel signaling pathways contributing to glomerular disease. Neurotrophic tyrosine kinase receptor 3
Junji Hamuro et al.
Investigative ophthalmology & visual science, 61(5), 47-47 (2020-05-27)
To clarify the expression profiles of ion channels and transporters of metabolic substrates among heterogeneous cultured human corneal endothelial cells (cHCECs) distinct in their effectiveness in reconstituting the corneal endothelium. Integrated proteomics for cell lysates by liquid chromatography-tandem mass spectrometry
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico